Table 2: Changes in Laboratory parameters (mean values) in both arms of the study over time.
Parameter |
Baseline |
Day 7 |
Change Baseline-day 7. (*day 2-baseline) |
P value Top: Day 7-baseline Bottom: Difference between arms at day 7 |
Inflammatory markers |
||||
ESR |
||||
Study Total |
12.8 |
11.4 |
1.37 |
0.0025* |
IVM |
12.9 |
10.98 |
1.88 |
0.257 |
IVM+ |
12.7 |
11.91 |
0.86 |
|
C-reactive Protein |
||||
Study total |
14.7 |
5.6 |
9.00 |
< 0.0001* |
IVM |
14.7 |
5.9 |
6.9 |
0.743 |
IVM+ |
14.7 |
5.4 |
7.4 |
|
D-Dimer FEU |
||||
Study total |
221.8 |
171.2 |
50.55 |
< 0.0001* |
IVM |
223.9 |
164.5 |
59.4 |
0.221 |
IVM+ |
220.6 |
178.1 |
41.7 |
|
Hematology |
||||
Hemoglobin |
||||
Study Total |
12.7 |
12.1 |
0.56 |
0.138 |
IVM |
12.9 |
12.3 |
0.67 |
0.615 |
IVM+ |
12.6 |
12.1 |
0.44 |
|
WBC |
||||
Study Total |
9.5 |
7.9 |
1.62 |
0.0002* |
IVM |
9.8 |
8.0 |
1.75 |
0.75 |
IVM+ |
9.3 |
7.8 |
1.49 |
|
Lymphocytes |
||||
Study total |
34.9 |
33.5 |
1.3 |
0.322 |
IVM |
32.4 |
32.7 |
-0.27 |
0.233 |
IVM+ |
37.3 |
34.4 |
2.2 |
|
Neutrophils |
||||
Study total |
59.2 |
51.8 |
7.31 |
0.0006* |
IVM |
58.6 |
51.7 |
6.9 |
0.838 |
IVM+ |
59.8 |
52.1 |
7.7 |
|
Neutrophil to Lymphocyte ratio (NLR) |
||||
Study total |
1.70 |
1.55 |
0.15 |
0.9102 |
IVM |
1.81 |
1.58 |
0.23 |
0.499 |
IVM+ |
1.60 |
1.52 |
0.08 |
|
Platelet count × 109/liter |
||||
Study total |
204.1 |
153.8 |
49.7 |
< 0.0001* |
IVM |
211.5 |
148.8 |
62.7 |
0.155 |
IVM+ |
197 |
158.7 |
36.8 |
|
Viral Cycle threshold (Ct) |
||||
N-Gene |
||||
Study total |
26.5 |
33.8 |
7.04* |
< 0.0001* |
IVM |
27.4 |
33.7 |
6.42* |
0.425 |
IVM+ |
25.7 |
33.8 |
7.68* |
|
E-gene Viral Cycle Time |
||||
Study total |
20.9 |
28.6 |
7.62* |
< 0.0001* |
IVM |
21.2 |
27.8 |
6.53* |
0.133 |
IVM+ |
20.7 |
29.5 |
8.71* |
|
SpO2 |
||||
Study total |
92.9 |
97.7 |
4.78 |
< 0.0001* |
IVM |
93.8 |
97.8 |
3.5 |
0.0189* |
IVM+ |
92 |
97.5 |
6 |